Wall Street Journal -- Medical-device maker C.R. Bard Inc. (BCR) said Monday it has a new cost-curbing and restructuring plan that will include an undefined number of staffing cuts. “The plan includes the realignment of certain manufacturing, sales and marketing, and administrative functions,” Bard said in a filing with the Securities and Exchange Commission. “The company expects this plan to result in the elimination of certain positions and other employee terminations worldwide.”
